SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
JAB Holdings B.V.

(Last) (First) (Middle)
PIET HEINKADE 55

(Street)
AMSTERDAM P7 1019 GM

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Keurig Dr Pepper Inc. [ KDP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2020
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 08/17/2020 S 45,000,000(1)(2) D $29 681,084,122 I See Footnote(3)
Common Stock, par value $0.01 per share 14,780,000 D(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
JAB Holdings B.V.

(Last) (First) (Middle)
PIET HEINKADE 55

(Street)
AMSTERDAM P7 1019 GM

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
JAB Forest B.V.

(Last) (First) (Middle)
PIET HEINKADE 55

(Street)
AMSTERDAM P7 1019 GM

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
JAB Investments S.a r.l.

(Last) (First) (Middle)
4, RUE JEAN MONNET

(Street)
LUXEMBOURG N4 L-2180

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
JAB Holding Co s.a r.l.

(Last) (First) (Middle)
4, RUE JEAN MONNET

(Street)
LUXEMBOURG N4 L-2180

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Joh. A. Benckiser B.V.

(Last) (First) (Middle)
OOSTERDOKSSTRAAT 80

(Street)
AMSTERDAM P7 1011 DK

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Agnaten SE

(Last) (First) (Middle)
ROOSEVELTPLATZ 4-5
TOP 10

(Street)
VIENNA C4 A-1090

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Lucresca SE

(Last) (First) (Middle)
ROOSEVELTPLATZ 4-5
TOP 10

(Street)
VIENNA C4 A-1090

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. On August 17, 2020, Maple Holdings B.V. agreed to sell (the "Share Sale") 45,000,000 shares of common stock, par value $0.01 per share, of Keurig Dr Pepper Inc. (the "Shares") to Goldman Sachs & Co. LLC (the "Underwriter"), pursuant to an Underwriting Agreement, by and among Maple Holdings B.V., Keurig Dr Pepper Inc. and the Underwriter.
2. On the basis of JAB Forest B.V.'s beneficial ownership of Acorn Holdings B.V., the Share Sale may be deemed a sale of Shares by each Reporting Person herein to the extent of such Reporting Person's pecuniary interest therein.
3. These Shares are held by Maple Holdings B.V. On the basis of JAB Forest B.V.'s beneficial ownership of Acorn Holdings B.V., each Reporting Person herein may be deemed a beneficial owner of Shares held by Maple Holdings B.V. Each of the Reporting Persons disclaims beneficial ownership of such Shares, except to the extent of its pecuniary interests therein.
4. These Shares are held and beneficially owned by JAB Holdings B.V., a direct or indirect subsidiary of each other Reporting Person herein, other than JAB Forest B.V. As such, each other Reporting Person herein, other than JAB Forest B.V., may be deemed a beneficial owner of Shares held by JAB Holdings B.V. Each such Reporting Person disclaims beneficial ownership of such Shares, except to the extent of its pecuniary interests therein.
Remarks:
To satisfy obligations that may arise under Section 16(b) of the Securities Exchange Act of 1934 in connection with, on the one hand, the transactions reported herein and, on the other hand, the March 9, 2020 purchase of 7,400,000 Shares and the May 22, 2020 purchase of 7,380,000 Shares reported by the Reporting Persons on March 11, 2020 and May 22, 2020, respectively, in each case in a Form 4 filed with the Securities and Exchange Commission (the "Commission"), on August 19, 2020 JAB Holdings paid $6,738,202 to KDP by wire transfer of immediately available funds. As disclosed by the Reporting Persons in the Forms 4 filed with the Commission on May 22, 2020 and June 11, 2020, JAB Holdings previously paid $740,000 and $21,343,798, respectively, to KDP in respect of any such obligations arising in connection with the transactions reported in Forms 4 filed with the Commission on March 11, 2020, May 22, 2020 and June 11, 2020.
/s/ Joachim Creus, Director of JAB Holdings B.V. in its capacity as Managing Director of JAB Forest B.V.; /s/ Fabien Simon, Director of JAB Holdings B.V. in its capacity as Managing Director of JAB Forest B.V. 08/19/2020
/s/ Joachim Creus, Director of JAB Holdings B.V.; /s/ Fabien Simon, Director of JAB Holdings B.V. 08/19/2020
/s/ Joachim Creus, Manager of JAB Investments s.a r.l.; /s/ Philippe Chenu, Manager of JAB Investments s.a r.l. 08/19/2020
/s/ Constantin Thun, Manager of JAB Holding Company s.a r.l.; /s/ Joachim Creus, Manager of JAB Holding Company s.a r.l. 08/19/2020
/s/ Joachim Creus, Director of Joh. A. Benckiser B.V.; /s/ Fabien Simon, Director of Joh. A. Benckiser B.V. 08/19/2020
/s/ Joachim Creus, Authorized Representative of Lucresca SE 08/19/2020
/s/ Joachim Creus, Authorized Representative of Agnaten SE 08/19/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.